Expression profiling of metalloproteinases and their inhibitors in cartilage

Lara Kevorkian, David A. Young, Clare Darrah, +7

Arthritis & Rheumatism

Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage

Rose K. Davidson, Jasmine G. Waters, Lara Kevorkian, +4

Arthritis Research & Therapy

Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption

David A. Young, Rachel Lakey, Caroline J. Pennington, +5

Arthritis Research & Therapy

Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer

Charlene Porter, Sylvia Armstrong‐Fisher, Tim Kopotsha, +4

Journal of Reproductive Immunology

Vitro TranscytosisLaboratory ImmunologyImmunologyImmune RegulationFcrn-mediated Transcytosis +23

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Bryan Smith, Rocío Lledó‐García, Kate L. Dixon, +20

mAbs

Immunocytochemical TechniqueImmunotoxicologyAntibody IsolationImmunologyImmunotherapeutics +16

Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis

Jennifer M Milner, Lara Kevorkian, David A. Young, +10

Arthritis Research & Therapy

Expression and function of matrix metalloproteinase (MMP)-28

Ursula R. Rodgers, Lara Kevorkian, Alison K. Surridge, +7

Matrix Biology

InflammationSclerostinProtein ExpressionBone Morphogenic ProteinMetalloprotein +13

Characterization and regulation of ADAMTS-16

Alison K. Surridge, Ursula R. Rodgers, T.E. Swingler, +7

Matrix Biology

<i>MMP28</i> gene expression is regulated by Sp1 transcription factor acetylation

T.E. Swingler, Lara Kevorkian, Kirsty L. Culley, +5

Biochemical Journal

GeneticsImmunologyDermatologyTumor BiologyTranscriptional Regulation +15

FRI0162 Investigation into the binding affinity of certolizumab pegol to fcrn and functional consequences for fcrn-mediated transcytosis: comparison to infliximab, adalimumab and etanercept

Terry Baker, Lara Kevorkian, Andrew Nesbitt

Annals of the Rheumatic Diseases